{
  "experiment_id": "9ca526e703ad",
  "timestamp": "2025-11-12T11:43:07.274202",
  "task_name": "narrowing_of_broad_synonyms",
  "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "prompt": "You are a metadata curation assistant. Your task is to narrow broad synonyms in the provided metadata.\n\nThe input data contains metadata entries with broad, general terms that should be narrowed to more specific, precise terms. Please correct each entry by replacing broad synonyms with their narrower, more specific equivalents.\n\nReturn the corrected metadata as JSON with the same structure as the input. Each field should be corrected to use more precise terminology appropriate for the specific context.\n\n",
  "num_samples": 10,
  "results": [
    {
      "sample_index": 0,
      "input": {
        "id": "syn17774134",
        "diagnosis": "Neurofibromatosis",
        "assay": "DNA sequencing",
        "tumorType": "Neurofibroma"
      },
      "response": {
        "success": true,
        "content": "```json\n{\n  \"id\": \"syn17774134\",\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Plexiform neurofibroma\"\n}\n```\n\n**Explanation of narrowing changes:**\n\n1. **diagnosis**: \"Neurofibromatosis\" \u2192 \"Neurofibromatosis type 1\" (NF1 is the most common form and most frequently associated with neurofibromas)\n\n2. **assay**: \"DNA sequencing\" \u2192 \"whole genome sequencing\" (more specific sequencing methodology commonly used in tumor genomic studies)\n\n3. **tumorType**: \"Neurofibroma\" \u2192 \"Plexiform neurofibroma\" (the most clinically significant subtype of neurofibroma associated with NF1, with potential for malignant transformation)",
        "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
        "usage": {
          "input_tokens": 204,
          "cache_creation_input_tokens": 0,
          "cache_read_input_tokens": 0,
          "output_tokens": 212
        },
        "attempt": 1
      },
      "score": 0.013157894736842105,
      "ground_truth": {
        "id": "syn17774134",
        "diagnosis": "Neurofibromatosis type 1",
        "assay": "whole exome sequencing",
        "tumorType": "Plexiform Neurofibroma"
      }
    },
    {
      "sample_index": 1,
      "input": {
        "id": "syn21296150",
        "diagnosis": "NF",
        "assay": "exome sequencing",
        "tumorType": "sarcoma"
      },
      "response": {
        "success": true,
        "content": "```json\n{\n  \"id\": \"syn21296150\",\n  \"diagnosis\": \"neurofibromatosis\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"malignant peripheral nerve sheath tumor\"\n}\n```\n\n**Corrections made:**\n\n1. **\"NF\"** \u2192 **\"neurofibromatosis\"** - Expanded the abbreviation to the full, more specific medical term\n2. **\"exome sequencing\"** \u2192 **\"whole exome sequencing\"** - Used the complete, standardized terminology for this genomic assay\n3. **\"sarcoma\"** \u2192 **\"malignant peripheral nerve sheath tumor\"** - Narrowed from the broad category \"sarcoma\" to the specific sarcoma type most commonly associated with neurofibromatosis (MPNST)",
        "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
        "usage": {
          "input_tokens": 198,
          "cache_creation_input_tokens": 0,
          "cache_read_input_tokens": 0,
          "output_tokens": 199
        },
        "attempt": 1
      },
      "score": 0.06756756756756757,
      "ground_truth": {
        "id": "syn21296150",
        "diagnosis": "Neurofibromatosis type 1",
        "assay": "whole exome sequencing",
        "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
      }
    },
    {
      "sample_index": 2,
      "input": {
        "id": "syn53204725",
        "diagnosis": "Neurofibromatoses",
        "assay": "assay by high throughput sequencer",
        "tumorType": "Nerve Sheath Neoplasm"
      },
      "response": {
        "success": true,
        "content": "```json\n{\n  \"id\": \"syn53204725\",\n  \"diagnosis\": \"Neurofibromatosis\",\n  \"assay\": \"whole genome sequencing assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Neurofibromatoses\" \u2192 \"Neurofibromatosis\" - Narrowed to the singular form, which is more standard for clinical diagnosis terminology\n\n2. **assay**: \"assay by high throughput sequencer\" \u2192 \"whole genome sequencing assay\" - Replaced the broad term with a specific sequencing assay type. High throughput sequencing encompasses many methods; whole genome sequencing is a precise, commonly used assay type\n\n3. **tumorType**: \"Nerve Sheath Neoplasm\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\" - Narrowed from the general category of nerve sheath neoplasms to the specific malignant tumor type (MPNST), which is the most common malignant tumor associated with neurofibromatosis",
        "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
        "usage": {
          "input_tokens": 213,
          "cache_creation_input_tokens": 0,
          "cache_read_input_tokens": 0,
          "output_tokens": 264
        },
        "attempt": 1
      },
      "score": 0.054945054945054944,
      "ground_truth": {
        "id": "syn53204725",
        "diagnosis": "Neurofibromatosis type 1",
        "assay": "whole genome sequencing",
        "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
      }
    },
    {
      "sample_index": 3,
      "input": {
        "id": "syn20705381",
        "diagnosis": "neurocutaneous syndrome",
        "assay": "spectroscopy",
        "tumorType": "unknown"
      },
      "response": {
        "success": true,
        "content": "```json\n{\n  \"id\": \"syn20705381\",\n  \"diagnosis\": \"neurofibromatosis type 1\",\n  \"assay\": \"mass spectrometry\",\n  \"tumorType\": \"neurofibroma\"\n}\n```\n\n**Rationale for narrowing:**\n\n- **\"neurocutaneous syndrome\"** \u2192 **\"neurofibromatosis type 1\"**: Neurocutaneous syndromes include multiple conditions (neurofibromatosis, tuberous sclerosis, Sturge-Weber syndrome, etc.). Neurofibromatosis type 1 (NF1) is the most common and clinically relevant specific diagnosis.\n\n- **\"spectroscopy\"** \u2192 **\"mass spectrometry\"**: Spectroscopy is a broad category encompassing many techniques (NMR, IR, UV-Vis, mass spectrometry, etc.). Mass spectrometry is the most commonly used spectroscopic technique in biomedical research and clinical diagnostics.\n\n- **\"unknown\"** \u2192 **\"neurofibroma\"**: Given the diagnosis of neurofibromatosis type 1, the most characteristic and common tumor type would be neurofibroma, which are benign peripheral nerve sheath tumors that are hallmark features of NF1.",
        "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
        "usage": {
          "input_tokens": 198,
          "cache_creation_input_tokens": 0,
          "cache_read_input_tokens": 0,
          "output_tokens": 294
        },
        "attempt": 1
      },
      "score": 0.009615384615384616,
      "ground_truth": {
        "id": "syn20705381",
        "diagnosis": "Neurofibromatosis type 1",
        "assay": "conventional MRI",
        "tumorType": "Unknown"
      }
    },
    {
      "sample_index": 4,
      "input": {
        "id": "syn26067698",
        "diagnosis": "Not Applicable",
        "assay": "immunoassay",
        "tumorType": "neurofibroma"
      },
      "response": {
        "success": true,
        "content": "```json\n{\n  \"id\": \"syn26067698\",\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"enzyme-linked immunosorbent assay\",\n  \"tumorType\": \"plexiform neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **assay**: Narrowed \"immunoassay\" to \"enzyme-linked immunosorbent assay\" (ELISA), which is a specific type of immunoassay commonly used in research and clinical settings.\n\n2. **tumorType**: Narrowed \"neurofibroma\" to \"plexiform neurofibroma\", which is a more specific subtype of neurofibroma. This is a clinically significant distinction as plexiform neurofibromas are associated with neurofibromatosis type 1 (NF1) and have different clinical implications than other neurofibroma subtypes.",
        "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
        "usage": {
          "input_tokens": 200,
          "cache_creation_input_tokens": 0,
          "cache_read_input_tokens": 0,
          "output_tokens": 209
        },
        "attempt": 1
      },
      "score": 0.0,
      "ground_truth": {
        "id": "syn26067698",
        "diagnosis": "Not Applicable",
        "assay": "immunohistochemistry",
        "tumorType": "Cutaneous Neurofibroma"
      }
    },
    {
      "sample_index": 5,
      "input": {
        "id": "syn58802671",
        "diagnosis": "neurofibromatosis",
        "assay": "plate based reporter assay",
        "tumorType": "benign neurofibroma"
      },
      "response": {
        "success": true,
        "content": "```json\n{\n  \"id\": \"syn58802671\",\n  \"diagnosis\": \"neurofibromatosis type 1\",\n  \"assay\": \"luciferase reporter assay\",\n  \"tumorType\": \"cutaneous neurofibroma\"\n}\n```\n\n**Explanation of narrowing changes:**\n\n1. **diagnosis**: \"neurofibromatosis\" \u2192 \"neurofibromatosis type 1\" (NF1 is the most common form and most frequently associated with neurofibromas)\n\n2. **assay**: \"plate based reporter assay\" \u2192 \"luciferase reporter assay\" (the most common specific type of plate-based reporter assay)\n\n3. **tumorType**: \"benign neurofibroma\" \u2192 \"cutaneous neurofibroma\" (the most common specific subtype of benign neurofibroma in neurofibromatosis)",
        "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
        "usage": {
          "input_tokens": 206,
          "cache_creation_input_tokens": 0,
          "cache_read_input_tokens": 0,
          "output_tokens": 209
        },
        "attempt": 1
      },
      "score": 0.015151515151515152,
      "ground_truth": {
        "id": "syn58802671",
        "diagnosis": "Neurofibromatosis type 1",
        "assay": "cell viability assay",
        "tumorType": "Cutaneous Neurofibroma"
      }
    },
    {
      "sample_index": 6,
      "input": {
        "id": "syn18145387",
        "diagnosis": "RASopathy",
        "assay": "immunoassay",
        "tumorType": "NFIB"
      },
      "response": {
        "success": true,
        "content": "```json\n{\n  \"id\": \"syn18145387\",\n  \"diagnosis\": \"Noonan syndrome\",\n  \"assay\": \"enzyme-linked immunosorbent assay\",\n  \"tumorType\": \"neurofibromatosis type 1B\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"RASopathy\" \u2192 \"Noonan syndrome\" - RASopathy is a broad category of genetic syndromes caused by mutations in the RAS/MAPK pathway. Noonan syndrome is the most common and specific RASopathy.\n\n2. **assay**: \"immunoassay\" \u2192 \"enzyme-linked immunosorbent assay\" - Immunoassay is a broad category; ELISA (enzyme-linked immunosorbent assay) is a specific, commonly used immunoassay technique.\n\n3. **tumorType**: \"NFIB\" \u2192 \"neurofibromatosis type 1B\" - Expanded the abbreviation to the full, specific term for clarity and precision.",
        "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
        "usage": {
          "input_tokens": 201,
          "cache_creation_input_tokens": 0,
          "cache_read_input_tokens": 0,
          "output_tokens": 245
        },
        "attempt": 1
      },
      "score": 0.012345679012345678,
      "ground_truth": {
        "id": "syn18145387",
        "diagnosis": "Neurofibromatosis type 1",
        "assay": "immunocytochemistry",
        "tumorType": "Cutaneous Neurofibroma"
      }
    },
    {
      "sample_index": 7,
      "input": {
        "id": "syn20705688",
        "diagnosis": "NF",
        "assay": "medical imaging",
        "tumorType": "unknown"
      },
      "response": {
        "success": true,
        "content": "```json\n{\n  \"id\": \"syn20705688\",\n  \"diagnosis\": \"neurofibromatosis\",\n  \"assay\": \"radiography\",\n  \"tumorType\": \"not reported\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"NF\" \u2192 \"neurofibromatosis\" - Expanded the abbreviation to the full, more specific medical term\n2. **assay**: \"medical imaging\" \u2192 \"radiography\" - Narrowed from the broad category to a more specific imaging modality (most common for NF diagnosis and monitoring)\n3. **tumorType**: \"unknown\" \u2192 \"not reported\" - More precise terminology indicating the information was not provided rather than being unknowable",
        "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
        "usage": {
          "input_tokens": 194,
          "cache_creation_input_tokens": 0,
          "cache_read_input_tokens": 0,
          "output_tokens": 167
        },
        "attempt": 1
      },
      "score": 0.0,
      "ground_truth": {
        "id": "syn20705688",
        "diagnosis": "Neurofibromatosis type 1",
        "assay": "conventional MRI",
        "tumorType": "Unknown"
      }
    },
    {
      "sample_index": 8,
      "input": {
        "id": "syn18638256",
        "diagnosis": "neurocristopathy",
        "assay": "transcriptomics",
        "tumorType": "neurolemmoma"
      },
      "response": {
        "success": true,
        "content": "```json\n{\n  \"id\": \"syn18638256\",\n  \"diagnosis\": \"schwannoma\",\n  \"assay\": \"RNA sequencing\",\n  \"tumorType\": \"schwannoma\"\n}\n```\n\n**Explanation of narrowing:**\n\n- **diagnosis**: \"neurocristopathy\" (broad term for disorders of neural crest-derived tissues) \u2192 \"schwannoma\" (specific diagnosis matching the tumor type)\n- **assay**: \"transcriptomics\" (broad term for any RNA expression study) \u2192 \"RNA sequencing\" (specific modern transcriptomics method)\n- **tumorType**: \"neurolemmoma\" (older/alternative broad synonym) \u2192 \"schwannoma\" (current standard specific terminology for this benign nerve sheath tumor)",
        "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
        "usage": {
          "input_tokens": 202,
          "cache_creation_input_tokens": 0,
          "cache_read_input_tokens": 0,
          "output_tokens": 178
        },
        "attempt": 1
      },
      "score": 0.0,
      "ground_truth": {
        "id": "syn18638256",
        "diagnosis": "NF2-related schwannomatosis",
        "assay": "RNA-seq",
        "tumorType": "schwannoma"
      }
    },
    {
      "sample_index": 9,
      "input": {
        "id": "syn26997360",
        "diagnosis": "phakomatosis",
        "assay": "viability assay",
        "tumorType": "tumor of cranial and spinal nerves"
      },
      "response": {
        "success": true,
        "content": "```json\n{\n  \"id\": \"syn26997360\",\n  \"diagnosis\": \"neurofibromatosis\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"nerve sheath tumor\"\n}\n```\n\n**Explanation of narrowing:**\n\n1. **\"phakomatosis\"** \u2192 **\"neurofibromatosis\"**: Phakomatosis is a broad term for neurocutaneous syndromes. Given the tumor type context (cranial and spinal nerves), neurofibromatosis is the most specific and relevant phakomatosis subtype.\n\n2. **\"viability assay\"** \u2192 **\"cell viability assay\"**: This specifies that the assay measures cellular viability rather than other types (e.g., tissue viability, organism viability).\n\n3. **\"tumor of cranial and spinal nerves\"** \u2192 **\"nerve sheath tumor\"**: This is the more specific histological classification for tumors arising from the nerve sheath cells of cranial and spinal nerves, which is particularly relevant in the context of neurofibromatosis.",
        "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
        "usage": {
          "input_tokens": 206,
          "cache_creation_input_tokens": 0,
          "cache_read_input_tokens": 0,
          "output_tokens": 258
        },
        "attempt": 1
      },
      "score": 0.030927835051546393,
      "ground_truth": {
        "id": "syn26997360",
        "diagnosis": "Neurofibromatosis type 1",
        "assay": "3D microtissue viability",
        "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
      }
    }
  ],
  "metrics": {
    "total_samples": 10,
    "successful_runs": 10,
    "failed_runs": 0,
    "success_rate": 1.0,
    "average_score": 0.020371093108025644,
    "min_score": 0.0,
    "max_score": 0.06756756756756757,
    "num_scored": 10
  }
}